LEADER 01545nam  2200373Ia 450 
001 9910698837803321
005 20090521141653.0
035   $a(CKB)5470000002397489
035   $a(OCoLC)335013499
035   $a(EXLCZ)995470000002397489
100   $a20090521d2004      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry and clinical investigators$b[electronic resource] $ethe use of clinical holds following clinical investigator misconduct
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research :$cCenter for Drug Evaluation and Research,$d[2004]
215   $a8 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 21, 2009).
300   $a"September 2004".
517   $aGuidance for industry and clinical investigators 
606   $aMedical research personnel$xGovernment policy$zUnited States
606   $aMedicine$xResearch$xGovernment policy$zUnited States
615  0$aMedical research personnel$xGovernment policy
615  0$aMedicine$xResearch$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698837803321
996   $aGuidance for industry and clinical investigators$93453575
997   $aUNINA